相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment of central giant cell granuloma in children with denosumab
Michelle Choe et al.
PEDIATRIC BLOOD & CANCER (2021)
Outcomes of Zoledronic Acid Use in Paediatric Conditions
Angelina Lim et al.
HORMONE RESEARCH IN PAEDIATRICS (2021)
Effect of vitamin K2 and vitamin D3 on bone mineral density in children with acute lymphoblastic leukemia: a prospective cohort study
Ismail Solmaz et al.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2021)
Associations between serum calcium, 25(OH)D level and bone mineral density in adolescents
Kaiyu Pan et al.
ADVANCES IN RHEUMATOLOGY (2021)
Skeletal Aging and Osteoporosis: Mechanisms and Therapeutics
Abhishek Chandra et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The impact of diet, body composition, and physical activity on child bone mineral density at five years of age-findings from the ROLO Kids Study
Marco K. McVey et al.
EUROPEAN JOURNAL OF PEDIATRICS (2020)
A Contemporary View of the Definition and Diagnosis of Osteoporosis in Children and Adolescents
Leanne M. Ward et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Effect of High-Dose vs Standard-Dose Vitamin D Supplementation in Pregnancy on Bone Mineralization in Offspring Until Age 6 Years A Prespecified Secondary Analysis of a Double-Blinded, Randomized Clinical Trial
Nicklas Brustad et al.
JAMA PEDIATRICS (2020)
Bone mineral density in young adults: the influence of vitamin D status, biochemical indicators, physical activity and body composition
Anna Kopiczko et al.
ARCHIVES OF OSTEOPOROSIS (2020)
Dense sclerotic metaphyseal bands caused by denosumab therapy
Shane Dunnion et al.
PEDIATRIC RADIOLOGY (2020)
Medication-related osteonecrosis of the jaw in a Duchenne muscular dystrophy patient
Luana Campos et al.
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2020)
Positive Outcomes of Denosumab Treatment in 2 Patients With Cherubism
Eitan Bar Droma et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2020)
Case Report: Safety and Efficacy of Denosumab in Four Children With Noonan Syndrome With Multiple Giant Cell Lesions of the Jaw
Kristen Ferriero et al.
FRONTIERS IN PEDIATRICS (2020)
Glucocorticoid-Induced Osteoporosis: Why Kids Are Different
Leanne M. Ward
FRONTIERS IN ENDOCRINOLOGY (2020)
Management of primary and secondary osteoporosis in children
Sophia D. Sakka et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2020)
TBS as a Tool to Differentiate the Impact of Antiresorptives on Cortical and Trabecular Bone in Children With Osteogenesis Imperfecta
Mirko Rehberg et al.
JOURNAL OF CLINICAL DENSITOMETRY (2019)
Pregnancy and newborn outcomes after exposure to bisphosphonates: a case-control study
A. Sokal et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Glucocorticoid-induced osteoporosis: 2019 concise clinical review
G. Adami et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Effect of Vitamin D and Calcium Supplementation on Bone Mineral Content in Children with Thalassemia
N. R. Thiagarajan et al.
INDIAN PEDIATRICS (2019)
The Utility of DXA Assessment at the Forearm, Proximal Femur, and Lateral Distal Femur, and Vertebral Fracture Assessment in the Pediatric Population: 2019 ISCD Official Position
David R. Weber et al.
JOURNAL OF CLINICAL DENSITOMETRY (2019)
Denosumab for treating aneurysmal bone cysts in children
Sebastien Raux et al.
ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH (2019)
Individualized treatment with denosumab in children with osteogenesis imperfecta - follow up of a trial cohort
Heike Hoyer-Kuhn et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
Nosology and classification of genetic skeletal disorders: 2019 revision
Geert R. Mortier et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2019)
Osteoporosis-pseudoglioma syndrome: clinical, genetic, and treatment-response study of 10 new cases in Greece
Iordanis Papadopoulos et al.
EUROPEAN JOURNAL OF PEDIATRICS (2019)
Effect of Anti-TGF-β Treatment in a Mouse Model of Severe Osteogenesis Imperfecta
Josephine T. Tauer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study
Michael R. McClung et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trial
Madeleine Rooney et al.
ECLINICALMEDICINE (2019)
Use of Denosumab in Children With Osteoclast Bone Dysplasias: Report of Three Cases
Alexander Upfill-Brown et al.
JBMR PLUS (2019)
Osteonecrosis of the Jaw and Rebound Hypercalcemia in Young People Treated With Denosumab for Giant Cell Tumor of Bone
Suma Uday et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Diagnosis of Recurrent Fracture in a Pediatric Cohort
M. Fiscaletti et al.
CALCIFIED TISSUE INTERNATIONAL (2018)
Inflammation in bone physiology and pathology
Iannis E. Adamopoulos
CURRENT OPINION IN RHEUMATOLOGY (2018)
Consensus guidelines on the use of bisphosphonate therapy in children and adolescents
Peter J. Simm et al.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2018)
Vitamin D Intervention and Bone: A Randomized Clinical Trial in Fair- and Dark-skinned Children at Northern Latitudes
Pia Karlsland Akeson et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2018)
Bone Health and Osteoporosis Management of the Patient With Duchenne Muscular Dystrophy
Leanne M. Ward et al.
PEDIATRICS (2018)
Efficacy and Safety of Denosumab Therapy for Osteogenesis Imperfecta Patients with Osteoporosis-Case Series
Tsukasa Kobayashi et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Efficacy and treatment costs of zoledronate versus pamidronate in paediatric osteoporosis
Vrinda Saraff et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2018)
Amalgamated Reference Data for Size-Adjusted Bone Densitometry Measurements in 3598 Children and Young Adults-the ALPHABET Study
Nicola J. Crabtree et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Biologic therapies and bone loss in rheumatoid arthritis
C. A. F. Zerbini et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Reduced Bone Mineral Density in Children With Screening-detected Celiac Disease
Sara Bjorck et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2017)
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
Kenneth G. Saag et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Clinical and biochemical response to neridronate treatment in a patient with osteoporosis-pseudoglioma syndrome (OPPG)
M. Celli et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Therapy with pamidronate in children with osteogenesis imperfecta
Otilia Marginean et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Denosumab: an Emerging Therapy in Pediatric Bone Disorders
Alison M. Boyce
CURRENT OSTEOPOROSIS REPORTS (2017)
Osteogenesis imperfecta
Joan C. Marini et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study
L. Idolazzi et al.
BONE (2017)
Osteoporosis in childhood
Francesco Vierucci et al.
CURRENT OPINION IN RHEUMATOLOGY (2017)
Pediatric Osteoporosis: Diagnosis and Treatment Considerations
Edoardo Marrani et al.
DRUGS (2017)
Severe hypercalcemia following denosumab treatment in a juvenile patient
Nokitaka Setsu et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2016)
Atypical femur fracture in an adolescent boy treated with bisphosphonates for X-linked osteoporosis based on PLS3 mutation
Denise M. van de Laarschot et al.
BONE (2016)
Osteogenesis Imperfecta Type VI in Individuals from Northern Canada
Leanne Ward et al.
CALCIFIED TISSUE INTERNATIONAL (2016)
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
F. Cosman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The impact of underlying disease on fracture risk and bone mineral density in children with rheumatic disorders: A review of current literature
Adam M. Huber et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2016)
Bisphosphonate therapy for osteogenesis imperfecta
Kerry Dwan et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
Fractures on bisphosphonates in osteoporosis pseudoglioma syndrome (OPPG): pQCT shows poor bone density and structure
Elizabeth A. Streeten et al.
BONE (2015)
New Genetic Forms of Childhood-Onset Primary Osteoporosis
Anders J. Kampe et al.
HORMONE RESEARCH IN PAEDIATRICS (2015)
Incident Vertebral Fractures and Risk Factors in the First Three Years Following Glucocorticoid Initiation Among Pediatric Patients With Rheumatic Disorders
Claire M. A. LeBlanc et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Osteotomy Healing in Children With Osteogenesis Imperfecta Receiving Bisphosphonate Treatment
Emad A. Anam et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Short-Term Safety of Zoledronic Acid in Young Patients With Bone Disorders: An Extensive Institutional Experience
Sobenna George et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
The Choice of Normative Pediatric Reference Database Changes Spine Bone Mineral Density Z-Scores But Not the Relationship Between Bone Mineral Density and Prevalent Vertebral Fractures
Jinhui Ma et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Osteosclerosis induced by denosumab
Eisuke Kobayashi et al.
LANCET (2015)
Critical Hypercalcemia Following Discontinuation of Denosumab Therapy for Metastatic Giant Cell Tumor of Bone
Nathan Gossai et al.
PEDIATRIC BLOOD & CANCER (2015)
Osteoporosis treatment with zoledronic acid in pediatric population at a university hospital in Western Saudi Arabia A 13-year experience
Abdulmoein E. Al-Agha et al.
SAUDI MEDICAL JOURNAL (2015)
Bone Loss Triggered by the Cytokine Network in Inflammatory Autoimmune Diseases
Dulshara Sachini Amarasekara et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Beneficial effects of intravenous pamidronate treatment in children with osteogenesis imperfecta under 24 months of age
Kirsten Kusumi et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2015)
Effects of Weight-Bearing Activities on Bone Mineral Content and Density in Children and Adolescents: A Meta-Analysis
Michael Behringer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Fracture Prediction and the Definition of Osteoporosis in Children and Adolescents: The ISCD 2013 Pediatric Official Positions
Nick Bishop et al.
JOURNAL OF CLINICAL DENSITOMETRY (2014)
Quantitative Computer Tomography in Children and Adolescents: The 2013 ISCD Pediatric Official Positions
Judith E. Adams et al.
JOURNAL OF CLINICAL DENSITOMETRY (2014)
Effects of Denosumab Treatment and Discontinuation on Human Growth Plates
Howard D. Wang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Evaluation of teriparatide treatment in adults with osteogenesis imperfecta
Eric S. Orwoll et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Excessive transforming growth factor-β signaling is a common mechanism in osteogenesis imperfecta
Ingo Grafel et al.
NATURE MEDICINE (2014)
Two years' experience with denosumab for children with Osteogenesis imperfecta type VI
Heike Hoyer-Kuhn et al.
ORPHANET JOURNAL OF RARE DISEASES (2014)
Cyclic Pamidronate Infusion for Neonatal-onset Osteogenesis Imperfecta
Chia-Hsuan Lin et al.
PEDIATRICS AND NEONATOLOGY (2014)
A systematic review and meta-analysis of glucocorticoid-induced osteoporosis in children
Karen E. Hansen et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2014)
Bone mass and quality in patients with juvenile idiopathic arthritis: longitudinal evaluation of bone-mass determinants by using dual-energy x-ray absorptiometry, peripheral quantitative computed tomography, and quantitative ultrasonography
Stefano Stagi et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Model-Based Assessment of Dosing Strategies in Children for Monoclonal Antibodies Exhibiting Target-Mediated Drug Disposition
S. Zheng et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2014)
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I
Davide Gatti et al.
CALCIFIED TISSUE INTERNATIONAL (2013)
Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts
Tobias Lange et al.
EUROPEAN SPINE JOURNAL (2013)
Intravenous Zoledronic Acid Given Every 6 Months in Childhood Osteoporosis
Hooi Leng Ooi et al.
HORMONE RESEARCH IN PAEDIATRICS (2013)
Pamidronate treatment stimulates the onset of recovery phase reducing fracture rate and skeletal deformities in patients with idiopathic juvenile osteoporosis: comparison with untreated patients
Giampiero I. Baroncelli et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2013)
Effects of RANK-Ligand Antibody (Denosumab) Treatment on Bone Turnover Markers in a Girl With Juvenile Paget's Disease
Corinna Grasemann et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches
Ernesto Canalis
NATURE REVIEWS ENDOCRINOLOGY (2013)
Osteoporosis-Pseudoglioma Syndrome: Three Novel Mutations in the LRP5 Gene and Response to Bisphosphonate Treatment
B. Tuysuz et al.
HORMONE RESEARCH IN PAEDIATRICS (2012)
Children and adolescents treated with neridronate for osteogenesis imperfecta show no evidence of any osteonecrosis of the jaw
Evelina Maines et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2012)
Denosumab treatment for fibrous dysplasia
Alison M. Boyce et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Methotrexate chemotherapy reduces osteogenesis but increases adipogenic potential in the bone marrow
Kristen R. Georgiou et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Prevention of bone loss in children receiving long-term glucocorticoids with calcium and alfacalcidol or menatetrenone
Pornpimol Rianthavorn et al.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2012)
Safety and efficacy of a 1-year treatment with zoledronic acid compared with pamidronate in children with osteogenesis imperfecta
Elizabete Ribeiro Barros et al.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2012)
DISEASE MECHANISMS Genetics of osteoporosis from genome-wide association studies: advances and challenges
J. Brent Richards et al.
NATURE REVIEWS GENETICS (2012)
The use of intravenous bisphosphonate therapy to treat vertebral fractures due to osteoporosis among boys with Duchenne muscular dystrophy
A. M. Sbrocchi et al.
OSTEOPOROSIS INTERNATIONAL (2012)
Review article: the effects of antitumour necrosis factor-α on bone metabolism in inflammatory bowel disease
S. G. Veerappan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Low bone mineral density is present in newly diagnosed paediatric systemic lupus erythematosus patients
Siok Hoon Lily Lim et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2 years of treatment in children with secondary osteoporosis
Peter J. Simm et al.
BONE (2011)
Population Pharmacokinetic Meta-Analysis of Denosumab in Healthy Subjects and Postmenopausal Women with Osteopenia or Osteoporosis
Liviawati Sutjandra et al.
CLINICAL PHARMACOKINETICS (2011)
Methotrexate Toxicity in Growing Long Bones of Young Rats: A Model for Studying Cancer Chemotherapy-Induced Bone Growth Defects in Children
Chiaming Fan et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Alendronate for the Treatment of Pediatric Osteogenesis Imperfecta: A Randomized Placebo-Controlled Study
L. M. Ward et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Treatment of symptomatic osteoporosis in children: a comparison of two pamidronate dosage regimens
Tania Martinez-Soto et al.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2011)
Radiographic Zebra Lines from Cyclical Pamidronate Therapy
Khaled M. Sarraf
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Effects of vitamin D supplementation on bone density in healthy children: systematic review and meta-analysis
Tania Winzenberg et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
A Randomized, Controlled Dose-Ranging Study of Risedronate in Children With Moderate and Severe Osteogenesis Imperfecta
Nick Bishop et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
The Relationship Between Fractures and DXA Measures of BMD in the Distal Femur of Children and Adolescents With Cerebral Palsy or Muscular Dystrophy
Richard C. Henderson et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Etanercept improves linear growth and bone mass acquisition in MTX-resistant polyarticular-course juvenile idiopathic arthritis
An D. Billiau et al.
RHEUMATOLOGY (2010)
Sclerotic metaphyseal lines in children and adolescents treated with alendronate
Erika C. C. Silva et al.
REVISTA BRASILEIRA DE REUMATOLOGIA (2010)
Risedronate in the Treatment of Mild Pediatric Osteogenesis Imperfecta: A Randomized Placebo-Controlled Study
Frank Rauch et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Osteoporosis-pseudoglioma syndrome: Description of 9 new cases and beneficial response to bisphosphonates
Elizabeth A. Streeten et al.
BONE (2008)
Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children?
J. J. Brown et al.
CLINICAL ENDOCRINOLOGY (2008)
Efficacy of intravenous alendronate for the treatment of glucocorticoid-induced osteoporosis in children with autoimmune diseases
Yuzaburo Inoue et al.
CLINICAL RHEUMATOLOGY (2008)
Bisphosphonate-induced osteopetrosis: Novel bone modeling defects, metaphyseal osteopenia, and osteosclerosis fractures after drug exposure ceases
Michael P. Whyte et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Bisphosphonates: Mechanism of action and role in clinical practice
Mathew T. Drake et al.
MAYO CLINIC PROCEEDINGS (2008)
Bone mineral content at birth is determined both by birth weight and fetal growth pattern
Jacques Beltrand et al.
PEDIATRIC RESEARCH (2008)
Prevalence of vitamin D deficiency and insufficiency in children with osteopenia or osteoporosis referred to a pediatric metabolic bone clinic
Sasigarn A. Bowden et al.
PEDIATRICS (2008)
Secondary osteoporosis in long-term bedridden patients with cerebral palsy
Toshiyuki Iwasaki et al.
PEDIATRICS INTERNATIONAL (2008)
Bone mineral apparent density in juvenile dermatomyositis: the role of lean body mass and glucocorticoid use
R. A. Santiago et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2008)
Low bone mineral density and decreased bone turnover in Duchenne muscular dystrophy
Ann-Charlott Soderpalm et al.
NEUROMUSCULAR DISORDERS (2007)
Acute phase response and mineral status following low dose intravenous zoledronic acid in children
Craig F. Munns et al.
BONE (2007)
Long-bone changes after pamidronate discontinuation in children and adolescents with osteogenesis imperfecta
Frank Rauch et al.
BONE (2007)
RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis
Kelly A. Rouster-Stevens et al.
ARTHRITIS AND RHEUMATISM (2007)
Vertebral morphometry in children and adolescents with osteogenesis imperfecta: Effect of intravenous pamidronate treatment
Christof Land et al.
BONE (2006)
Cyclical intravenous pamidronate treatment affects metaphyseal modeling in growing patients with osteogenesis imperfecta
C Land et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Review: developmental origins of osteoporotic fracture
C Cooper et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: A 3-year randomized placebo-controlled trial
G Chevrel et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Two-year clinical trial of oral alendronate versus intravenous pamidronate in children with osteogenesis imperfecta
LA DiMeglio et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-α antibody:: a prospective open-label pilot study
U Lange et al.
RHEUMATOLOGY (2005)
Impact of alendronate on quality of life in children with osteogenesis imperfecta
MG Seikaly et al.
JOURNAL OF PEDIATRIC ORTHOPAEDICS (2005)
Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: Clinical and histomorphometric outcome
CFJ Munns et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Bone status over 1 yr of etanercept treatment in juvenile idiopathic arthritis
G Simonini et al.
RHEUMATOLOGY (2005)
Effects of once-weekly oral alendronate on bone in children on glucocorticoid treatment
S Rudge et al.
RHEUMATOLOGY (2005)
Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement
AD Letocha et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Therapy Insight: osteoporosis in inflammatory bowel disease - advances and retreats
CN Bernstein et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2005)
Intravenous neridronate in children with osteogenesis imperfecta:: A randomized controlled study
D Gatti et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Pamidronate treatment of pediatric fracture patients on chronic steroid therapy
PD Acott et al.
PEDIATRIC NEPHROLOGY (2005)
Effective parenteral clodronate treatment of a child with severe juvenile idiopathic osteoporosis
R Melchior et al.
EUROPEAN JOURNAL OF PEDIATRICS (2005)
Treatment of osteopenia and osteoporosis in renal transplant children and adolescents
AA El-Husseini et al.
PEDIATRIC TRANSPLANTATION (2004)
Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate
CFJ Munns et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Short-term safety assessment in the use of intravenous zoledronic acid in children
W Hogler et al.
JOURNAL OF PEDIATRICS (2004)
Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta
LA DiMeglio et al.
BONE (2004)
Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study
R Sakkers et al.
LANCET (2004)
Brief report: Bisphosphonate-induced osteopetrosis
MP Whyte et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV
L Zeitlin et al.
PEDIATRICS (2003)
Treatment of symptomatic pediatric osteoporosis with cyclic single-day intravenous pamidronate infusions
J Steelman et al.
JOURNAL OF PEDIATRICS (2003)
Intravenous neridronate in adults with osteogenesis imperfecta
S Adami et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Idiopathic juvenile osteoporosis
RS Lorenc
CALCIFIED TISSUE INTERNATIONAL (2002)
Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta
E Åström et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2002)
Osteoporosis in children and adolescent girls: Case report of idiopathic juvenile osteoporosis and review of the literature
RP Kauffman et al.
OBSTETRICAL & GYNECOLOGICAL SURVEY (2001)
Osteoporosis pseudoglioma syndrome: Treatment of spinal osteoporosis with intravenous bisphosphonates
M Zacharin et al.
JOURNAL OF PEDIATRICS (2000)
分享论文
